Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Listed
Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 609 across all filing types
Latest filing 2026-04-06 Remuneration Information
Country IT Italy
Listing XMIL PHN · 5 venues

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
REPORT ON THE REMUNERATION POLICY AND COMPENSATION PAID
Remuneration Information Classification · 92% confidence The document is titled “Report on the Remuneration Policy and Compensation Paid” and is prepared pursuant to Article 123-ter of the Italian TUF and Article 84-quarter of Consob’s Issuers’ Regulation. It details the company’s remuneration policy for its Board of Directors and Statutory Auditors, describes the procedures for implementation, and provides analytics on compensation paid. This matches the definition of a Remuneration Information filing (detailed compensation report for executives and directors).
2026-04-06 English
PHN - Relazione sulla Politica di remunerazione e sui compensi corrisposti 2025
Remuneration Information Classification · 95% confidence The document is titled “Relazione sulla Politica di Remunerazione e sui compensi corrisposti,” prepared pursuant to art. 123-ter of the TUF and art. 84-quater of the CONSOB Issuers’ Regulation. It details the company’s remuneration policy, procedures, and the compensation paid to directors and statutory auditors in accordance with the regulatory schemes. This is precisely a Remuneration Information report (disclosure of executive and board compensation), matching filing category DEF 14A.
2026-04-06 Italian
Individual proposals for resolution
Proxy Solicitation & Information Statement Classification · 76% confidence The document is a submission by a significant shareholder (ALH S.r.l.) providing resolution proposals for the appointment of the Board of Directors at the upcoming Ordinary Shareholders’ Meeting of Pharmanutra S.p.A. The text constitutes proxy materials intended to inform and solicit votes from shareholders on specific agenda items (determination of board size, term, and director appointments). This aligns with the definition of a Proxy Solicitation & Information Statement (PSI) rather than an actual meeting notice, financial report, or voting results announcement.
2026-04-06 English
Proposte Individuali di delibera
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a letter from a significant shareholder to Pharmanutra S.p.A. presenting proposals for resolutions at the upcoming Ordinary Shareholders’ Meeting (27 April 2026) related to board composition. It is not the meeting minutes or voting results, but is material intended to inform shareholders and solicit their votes on the AGM agenda. This corresponds to a Proxy Solicitation & Information Statement (PSI).
2026-04-06 Italian
Lista nomina CdA presentata dai soci di minoranza
Major Shareholding Notification Classification · 85% confidence The document is a set of formal communications (letters and post-trading notifications) under Italian corporate law (Art. 43 Provvedimento Unico sul Post Trading and Art. 147-ter TUF) recording shareholdings and the deposit of director nomination lists by institutional investors. These filings provide ISIN, holder identity, share quantities, percentages and rights exercised (deposit of lists), matching our definition of notifications of significant share ownership changes/notifications. Therefore this is a Major Shareholding Notification (MRQ).
2026-04-06 Italian
Lista candidati presentata da azionista di maggioranza
Proxy Solicitation & Information Statement Classification · 75% confidence The document is a set of materials related to the upcoming ordinary shareholders’ meeting of Pharmanutra S.p.A., including the submission of a shareholder list of director candidates, statutory shareholding certificates (ex art. 43 post-trading), and individual acceptance and attestation declarations. These are not financial results or audit reports, nor are they a simple announcement of a change in board composition. Rather, they constitute the informational and proxy‐related materials connected to soliciting votes and presenting candidate slates at a shareholder meeting. As such, they best fit the Proxy Solicitation & Information Statement category (PSI).
2026-04-06 Italian

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.